Your browser doesn't support javascript.
loading
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.
Streby, Keri A; Parisi, Marguerite T; Shulkin, Barry L; LaBarre, Brian; Bagatell, Rochelle; Diller, Lisa; Grupp, Stephan A; Matthay, Katherine K; Voss, Stephan D; Yu, Alice L; London, Wendy B; Park, Julie R; Yanik, Gregory A; Naranjo, Arlene.
Affiliation
  • Streby KA; Division of Hematology/Oncology/BMT, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.
  • Parisi MT; Department of Radiology, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington, USA.
  • Shulkin BL; Department of Pediatrics, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington, USA.
  • LaBarre B; Department of Radiological Sciences, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Bagatell R; Children's Oncology Group Statistics & Data Center, Department of Biostatistics, University of Florida, Gainesville, Florida, USA.
  • Diller L; Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Grupp SA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Matthay KK; Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Voss SD; Department of Pediatrics, University of California San Francisco School of Medicine, San Francisco, California, USA.
  • Yu AL; Department of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • London WB; University of California in San Diego, San Diego, California, USA.
  • Park JR; Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
  • Yanik GA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Naranjo A; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pediatr Blood Cancer ; 70(8): e30418, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37199022
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Neuroblastoma Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Humans / Infant Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Neuroblastoma Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Humans / Infant Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States